Manufacturer
Novartis Pharmaceuticals
Pharmaceutical manufacturer based in Switzerland
Switzerland
- Products listed
- 135
- Molecules
- 54
- Therapy areas
- 13
Novartis Pharmaceuticals is a pharmaceutical manufacturer based in Switzerland. MedsAcross lists 135 of its products across 54 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Switzerland
- Indian manufacturer
- No
- Also listed as
- Novartis Pharmaceuticals Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Novartis Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
41 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Afinitor 10 mg tabletOral | Everolimus | US FDA | Available on request |
| Afinitor 2.5 mg tabletOral | Everolimus | US FDA | Available on request |
| Afinitor 5 mg tabletOral | Everolimus | US FDA | Available on request |
| Afinitor 7.5 mg tabletOral | Everolimus | US FDA | Available on request |
| Afinitor Disperz 2 mg tablet for oral suspensionOral | Everolimus | US FDA | Available on request |
| Afinitor Disperz 3 mg tablet for oral suspensionOral | Everolimus | US FDA | Available on request |
| Afinitor Disperz 5 mg tablet for oral suspensionOral | Everolimus | US FDA | Available on request |
| Femara 2.5 mg tabletOral | Letrozole | US FDA | Available on request |
| Gleevec 100 mg tabletOral | Imatinib | US FDA | Available on request |
| Gleevec 400 mg tabletOral | Imatinib | US FDA | Available on request |
| Hycamtin 4 mg/4 mL powder for injectionIntravenous | Topotecan | US FDA | Available on request |
| Kesimpta 20 mg/0.4 mL injectionSubcutaneous Cold chain | Ofatumumab | US FDA | Available on request |
| Kisqali 200 mg tabletOral | Ribociclib | US FDA | Available on request |
| Kymriah 2000000 injectable suspensionIntravenous | Tisagenlecleucel | US FDA | Available on request |
| Kymriah 60000000 injectable suspensionIntravenous | Tisagenlecleucel | US FDA | Available on request |
| Midostaurin 25 mg capsuleOralGeneric name | Midostaurin | US FDA | Available on request |
| Piqray kit | Alpelisib | US FDA | Available on request |
| Piqray 150 mg tabletOral | Alpelisib | US FDA | Available on request |
| Piqray 200 mg tabletOral | Alpelisib | US FDA | Available on request |
| Scemblix 100 mg tabletOral | Asciminib | US FDA | Available on request |
| Scemblix 20 mg tabletOral | Asciminib | US FDA | Available on request |
| Scemblix 40 mg tabletOral | Asciminib | US FDA | Available on request |
| Tabrecta 150 mg tabletOral | Capmatinib | US FDA | Available on request |
| Tabrecta 200 mg tabletOral | Capmatinib | US FDA | Available on request |
| Tafinlar 10 mg tablet for oral suspensionOral | Dabrafenib | US FDA | Available on request |
| Tafinlar 50 mg capsuleOral | Dabrafenib | US FDA | Available on request |
| Tafinlar 75 mg capsuleOral | Dabrafenib | US FDA | Available on request |
| Tasigna 150 mg capsuleOral | Nilotinib | US FDA | Available on request |
| Tasigna 200 mg capsuleOral | Nilotinib | US FDA | Available on request |
| Tasigna 50 mg capsuleOral | Nilotinib | US FDA | Available on request |
| Tykerb 250 mg tabletOral | Lapatinib | US FDA | Available on request |
| Vijoice kit | Alpelisib | US FDA | Available on request |
| Vijoice 125 mg tabletOral | Alpelisib | US FDA | Available on request |
| Vijoice 50 mg granulesOral | Alpelisib | US FDA | Available on request |
| Vijoice 50 mg tabletOral | Alpelisib | US FDA | Available on request |
| Votrient 200 mg tabletOral | Pazopanib | US FDA | Available on request |
| Zortress 0.25 mg tabletOral | Everolimus | US FDA | Available on request |
| Zortress 0.5 mg tabletOral | Everolimus | US FDA | Available on request |
| Zortress 0.75 mg tabletOral | Everolimus | US FDA | Available on request |
| Zortress 1 mg tabletOral | Everolimus | US FDA | Available on request |
| Zykadia 150 mg tabletOral | Ceritinib | US FDA | Available on request |
Immunology and transplant
21 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cosentyx 125 mg/5 mL injectionIntravenous Cold chain | Secukinumab | US FDA | Available on request |
| Cosentyx 150 mg/mL injectionSubcutaneous Cold chain | Secukinumab | US FDA | Available on request |
| Cosentyx 300 mg/2 mL injectionSubcutaneous Cold chain | Secukinumab | US FDA | Available on request |
| Cosentyx 75 mg/0.5 mL injectionSubcutaneous Cold chain | Secukinumab | US FDA | Available on request |
| Fabhalta 200 mg capsuleOral | Iptacopan | US FDA | Available on request |
| Gilenya 0.25 mg capsuleOral | Fingolimod | US FDA | Available on request |
| Gilenya 0.5 mg capsuleOral | Fingolimod | US FDA | Available on request |
| Ilaris 150 mg/1 mL injectionSubcutaneous Cold chain | Canakinumab | US FDA | Available on request |
| Mayzent 0.25 mg tabletOral Cold chain | Siponimod | US FDA | Available on request |
| Mayzent 1 mg tabletOral Cold chain | Siponimod | US FDA | Available on request |
| Mayzent 2 mg tabletOral Cold chain | Siponimod | US FDA | Available on request |
| Myfortic 180 mg delayed-release tabletOral | Mycophenolate | US FDA | Available on request |
| Myfortic 360 mg delayed-release tabletOral | Mycophenolate | US FDA | Available on request |
| Neoral 100 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Neoral 100 mg/mL oral solutionOral | Cyclosporine | US FDA | Available on request |
| Neoral 25 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Rhapsido 25 mg tabletOral | Remibrutinib | US FDA | Available on request |
| Sandimmune 100 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Sandimmune 25 mg capsuleOral | Cyclosporine | US FDA | Available on request |
| Sandimmune 250 mg/5 mL injectionIntravenous | Cyclosporine | US FDA | Available on request |
| Simulect 10 mg/2.5 mL powder for injectionIntravenous Cold chain | Basiliximab | US FDA | Available on request |
Cardiology
20 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Betoptic S 2.8 mg/mL ophthalmic suspensionOphthalmic | Betaxolol | US FDA | Available on request |
| Diovan 160 mg tabletOral | Valsartan | US FDA | Available on request |
| Diovan 320 mg tabletOral | Valsartan | US FDA | Available on request |
| Diovan 40 mg tabletOral | Valsartan | US FDA | Available on request |
| Diovan 80 mg tabletOral | Valsartan | US FDA | Available on request |
| Entresto 15 mg/16 mg oral pelletsOral | Sacubitril and Valsartan | US FDA | Available on request |
| Entresto 24 mg/26 mg tabletOral | Sacubitril and Valsartan | US FDA | Available on request |
| Entresto 49 mg/51 mg tabletOral | Sacubitril and Valsartan | US FDA | Available on request |
| Entresto 6 mg/6 mg oral pelletsOral | Sacubitril and Valsartan | US FDA | Available on request |
| Entresto 97 mg/103 mg tabletOral | Sacubitril and Valsartan | US FDA | Available on request |
| Exforge 10 mg/160 mg tabletOral | Amlodipine and Valsartan | US FDA | Available on request |
| Exforge 10 mg/320 mg tabletOral | Amlodipine and Valsartan | US FDA | Available on request |
| Exforge 5 mg/160 mg tabletOral | Amlodipine and Valsartan | US FDA | Available on request |
| Exforge 5 mg/320 mg tabletOral | Amlodipine and Valsartan | US FDA | Available on request |
| Exforge HCT 10 mg/12.5 mg/160 mg tabletOral | Amlodipine, Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Exforge HCT 10 mg/25 mg/160 mg tabletOral | Amlodipine, Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Exforge HCT 10 mg/25 mg/320 mg tabletOral | Amlodipine, Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Exforge HCT 5 mg/12.5 mg/160 mg tabletOral | Amlodipine, Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Exforge HCT 5 mg/25 mg/160 mg tabletOral | Amlodipine, Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Leqvio 284 mg/1.5 mL injectionSubcutaneous | Inclisiran | US FDA | Available on request |
Antidotes
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Desferal 500 mg powder for injectionIntramuscular, intravenous, subcutaneous | Deferoxamine | US FDA | Available on request |
| Exjade 125 mg tablet for oral suspensionOral | Deferasirox | US FDA | Available on request |
| Exjade 250 mg tablet for oral suspensionOral | Deferasirox | US FDA | Available on request |
| Exjade 500 mg tablet for oral suspensionOral | Deferasirox | US FDA | Available on request |
| Jadenu 180 mg tabletOral | Deferasirox | US FDA | Available on request |
| Jadenu 180 mg granulesOral | Deferasirox | US FDA | Available on request |
| Jadenu 360 mg granulesOral | Deferasirox | US FDA | Available on request |
| Jadenu 360 mg tabletOral | Deferasirox | US FDA | Available on request |
| Jadenu 90 mg granulesOral | Deferasirox | US FDA | Available on request |
| Jadenu 90 mg tabletOral | Deferasirox | US FDA | Available on request |
Neurology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tegretol 100 mg/5 mL oral suspensionOral | Carbamazepine | US FDA | Available on request |
| Tegretol 200 mg tabletOral | Carbamazepine | US FDA | Available on request |
| Tegretol XR 100 mg extended-release tabletOral | Carbamazepine | US FDA | Available on request |
| Tegretol XR 200 mg extended-release tabletOral | Carbamazepine | US FDA | Available on request |
| Tegretol XR 400 mg extended-release tabletOral | Carbamazepine | US FDA | Available on request |
| Trileptal 150 mg tabletOral | Oxcarbazepine | US FDA | Available on request |
| Trileptal 300 mg tabletOral | Oxcarbazepine | US FDA | Available on request |
| Trileptal 60 mg/mL oral suspensionOral | Oxcarbazepine | US FDA | Available on request |
| Trileptal 600 mg tabletOral | Oxcarbazepine | US FDA | Available on request |
Haematology
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Adakveo 100 mg/10 mL injectionIntravenous Cold chain | Crizanlizumab | US FDA | Available on request |
| Promacta 12.5 mg powder for oral suspensionOral | Eltrombopag | US FDA | Available on request |
| Promacta 12.5 mg tabletOral | Eltrombopag | US FDA | Available on request |
| Promacta 25 mg powder for oral suspensionOral | Eltrombopag | US FDA | Available on request |
| Promacta 25 mg tabletOral | Eltrombopag | US FDA | Available on request |
| Promacta 50 mg tabletOral | Eltrombopag | US FDA | Available on request |
| Promacta 75 mg tabletOral | Eltrombopag | US FDA | Available on request |
Endocrinology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Sandostatin 100 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Octreotide | US FDA | Available on request |
| Sandostatin 50 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Octreotide | US FDA | Available on request |
| Sandostatin 500 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Octreotide | US FDA | Available on request |
| Sandostatin LAR Depot kit Cold chain | Octreotide | US FDA | Available on request |
Psychiatry
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Exelon 4.6 mg/24 hours transdermal patchTransdermal | Rivastigmine | US FDA | Available on request |
| Exelon 9.5 mg/24 hours transdermal patchTransdermal | Rivastigmine | US FDA | Available on request |
| Focalin XR 20 mg extended-release capsuleOral | Dexmethylphenidate | US FDA | Available on request |
Ophthalmology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Beovu 6 mg/0.05 mL injectionIntravitreal Cold chain | Brolucizumab | US FDA | Available on request |
| Xiidra 50 mg/mL eye dropsOphthalmic | Lifitegrast | US FDA | Available on request |
Malaria
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Coartem 20 mg/120 mg tabletOral | Artemether and Lumefantrine | US FDA | Available on request |
Tuberculosis
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lamprene 50 mg capsuleOral | Clofazimine | US FDA | Available on request |
Contrast media and diagnostics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Locametz 25 mcg powder for injectionIntravenous | Gozetotide | US FDA | Available on request |
Antibiotics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tobrex 0.3% eye ointmentOphthalmic | Tobramycin | US FDA | Available on request |
Other products
14 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Diovan HCT 12.5 mg/160 mg tabletOral | Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Diovan HCT 12.5 mg/320 mg tabletOral | Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Diovan HCT 12.5 mg/80 mg tabletOral | Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Diovan HCT 25 mg/160 mg tabletOral | Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Diovan HCT 25 mg/320 mg tabletOral | Hydrochlorothiazide and Valsartan | US FDA | Available on request |
| Egaten 250 mg tabletOral | Triclabendazole | US FDA | Available on request |
| Maxitrol 1 mg/3.5 mg/10000 units per g eye ointmentOphthalmic | Dexamethasone, Neomycin and Polymyxin b | US FDA | Available on request |
| Mekinist 0.05 mg/mL powder for oral solutionOral Cold chain | Trametinib dimethyl sulfoxide | US FDA | Available on request |
| Mekinist 0.5 mg tabletOral Cold chain | Trametinib dimethyl sulfoxide | US FDA | Available on request |
| Mekinist 2 mg tabletOral Cold chain | Trametinib dimethyl sulfoxide | US FDA | Available on request |
| Pluvicto 27 mCi/mL injectionIntravenous | Lutetium lu-177 vipivotide tetraxetan | US FDA | Available on request |
| TobraDex 1 mg/3 mg per g eye ointmentOphthalmic | Dexamethasone and Tobramycin | US FDA | Available on request |
| Triesence 40 mg/1 mL injectable suspensionOphthalmic | Triamcinolone acetonide | US FDA | Available on request |
| Vanrafia 0.75 mg tabletOral | Atrasentan | US FDA | Available on request |
Molecules made
CrizanlizumabEverolimusBrolucizumabBetaxololArtemether and LumefantrineSecukinumabDeferoxamineValsartanHydrochlorothiazide and ValsartanTriclabendazoleSacubitril and ValsartanRivastigmineAmlodipine and ValsartanAmlodipine, Hydrochlorothiazide and ValsartanDeferasiroxIptacopanLetrozoleDexmethylphenidateFingolimodImatinibTopotecanCanakinumabOfatumumabRibociclibTisagenlecleucelClofazimineInclisiranGozetotideDexamethasone, Neomycin and Polymyxin bSiponimodTrametinib dimethyl sulfoxideMidostaurinMycophenolateCyclosporineAlpelisibLutetium lu-177 vipivotide tetraxetanEltrombopagRemibrutinibOctreotideAsciminibBasiliximabCapmatinibDabrafenibNilotinibCarbamazepineDexamethasone and TobramycinTobramycinTriamcinolone acetonideOxcarbazepineLapatinibAtrasentanPazopanibLifitegrastCeritinib
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Novartis Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.